
Daniel E. Kolker
Supervisory Patent Examiner (ID: 12246, Phone: (571)272-3181 , Office: P/1644 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1645, 1649, 1644, 1646 |
| Total Applications | 545 |
| Issued Applications | 178 |
| Pending Applications | 76 |
| Abandoned Applications | 291 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 121220
[patent_doc_number] => 07709225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Nucleic acids encoding mutations in sodium channels related to epilepsy'
[patent_app_type] => utility
[patent_app_number] => 11/262647
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16142
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709225.pdf
[firstpage_image] =>[orig_patent_app_number] => 11262647
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/262647 | Nucleic acids encoding mutations in sodium channels related to epilepsy | Oct 30, 2005 | Issued |
Array
(
[id] => 4669296
[patent_doc_number] => 20080044356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Assemblies of Oligomeric Amyloid Beta Protein and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/665670
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21838
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044356.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665670
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665670 | Assemblies of Oligomeric Amyloid Beta Protein and Uses Thereof | Oct 20, 2005 | Abandoned |
Array
(
[id] => 236186
[patent_doc_number] => 07595167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-29
[patent_title] => 'Alzheimer\'s disease-specific alterations of the Erk1/Erk2 phosphorylation ratio'
[patent_app_type] => utility
[patent_app_number] => 11/246524
[patent_app_country] => US
[patent_app_date] => 2005-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10400
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/595/07595167.pdf
[firstpage_image] =>[orig_patent_app_number] => 11246524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/246524 | Alzheimer's disease-specific alterations of the Erk1/Erk2 phosphorylation ratio | Oct 10, 2005 | Issued |
Array
(
[id] => 5799337
[patent_doc_number] => 20060034858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => utility
[patent_app_number] => 11/245524
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26344
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245524 | Prevention and treatment of amyloidogenic disease | Oct 6, 2005 | Abandoned |
Array
(
[id] => 8027407
[patent_doc_number] => 08142781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Fusion proteins for blood-brain barrier delivery'
[patent_app_type] => utility
[patent_app_number] => 11/245546
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 32077
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/142/08142781.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245546
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245546 | Fusion proteins for blood-brain barrier delivery | Oct 6, 2005 | Issued |
Array
(
[id] => 5753963
[patent_doc_number] => 20060223112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Novel receptor'
[patent_app_type] => utility
[patent_app_number] => 11/244538
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14493
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223112.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244538
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244538 | Novel receptor | Oct 5, 2005 | Abandoned |
Array
(
[id] => 5148276
[patent_doc_number] => 20070048335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Methods for treating pain and hyperhidrosis'
[patent_app_type] => utility
[patent_app_number] => 11/243198
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13583
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048335.pdf
[firstpage_image] =>[orig_patent_app_number] => 11243198
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/243198 | Methods for treating pain and hyperhidrosis | Oct 2, 2005 | Abandoned |
Array
(
[id] => 5023473
[patent_doc_number] => 20070149439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Pituitary adenylate cyclase-activating polypeptide (PACAP) is an anti-mitogenic signal for selected neuronal precursors in vivo'
[patent_app_type] => utility
[patent_app_number] => 11/240737
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10065
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149439.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240737
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240737 | Pituitary adenylate cyclase-activating polypeptide (PACAP) is an anti-mitogenic signal for selected neuronal precursors in vivo | Sep 29, 2005 | Abandoned |
Array
(
[id] => 4771865
[patent_doc_number] => 20080057523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Detection of Protein Aggregates by Homologous Elisa'
[patent_app_type] => utility
[patent_app_number] => 11/575230
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14896
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057523.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575230
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575230 | Detection of Protein Aggregates by Homologous Elisa | Sep 15, 2005 | Abandoned |
Array
(
[id] => 4976873
[patent_doc_number] => 20070218105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Topical Treatment with NGF and DHA in Damaged Corneas'
[patent_app_type] => utility
[patent_app_number] => 11/577239
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5834
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218105.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577239
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577239 | Topical Treatment with NGF and DHA in Damaged Corneas | Sep 15, 2005 | Abandoned |
Array
(
[id] => 5880883
[patent_doc_number] => 20060029966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/216875
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34212
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029966.pdf
[firstpage_image] =>[orig_patent_app_number] => 11216875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/216875 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Aug 25, 2005 | Abandoned |
Array
(
[id] => 274267
[patent_doc_number] => 07560431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => 'Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents'
[patent_app_type] => utility
[patent_app_number] => 11/202566
[patent_app_country] => US
[patent_app_date] => 2005-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 17
[patent_no_of_words] => 30302
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560431.pdf
[firstpage_image] =>[orig_patent_app_number] => 11202566
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/202566 | Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents | Aug 11, 2005 | Issued |
Array
(
[id] => 8151700
[patent_doc_number] => 08168188
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-05-01
[patent_title] => 'Antibody and utilization of the same'
[patent_app_type] => utility
[patent_app_number] => 11/659829
[patent_app_country] => US
[patent_app_date] => 2005-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 16802
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168188.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659829
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659829 | Antibody and utilization of the same | Aug 10, 2005 | Issued |
Array
(
[id] => 5844332
[patent_doc_number] => 20060122120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Method of reducing the effects of Abeta and compositions therefore'
[patent_app_type] => utility
[patent_app_number] => 11/200809
[patent_app_country] => US
[patent_app_date] => 2005-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22949
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122120.pdf
[firstpage_image] =>[orig_patent_app_number] => 11200809
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/200809 | Method of reducing the effects of Abeta and compositions therefore | Aug 9, 2005 | Abandoned |
Array
(
[id] => 5834635
[patent_doc_number] => 20060246465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/189442
[patent_app_country] => US
[patent_app_date] => 2005-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34222
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11189442
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/189442 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 24, 2005 | Abandoned |
Array
(
[id] => 5767892
[patent_doc_number] => 20060019386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Protein domain related to deafness, osteoarthritis and abnormal cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 11/186545
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10200
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019386.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186545
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186545 | Protein domain related to deafness, osteoarthritis and abnormal cell proliferation | Jul 20, 2005 | Abandoned |
Array
(
[id] => 4710513
[patent_doc_number] => 20080299039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier'
[patent_app_type] => utility
[patent_app_number] => 11/884629
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17230
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884629
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884629 | Aprotinin polypeptides for transporting a compound across the blood-brain barrier | Jul 20, 2005 | Issued |
Array
(
[id] => 4492182
[patent_doc_number] => 07955812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Methods of diagnosing alzheimer\'s disease by detecting antibodies to cross-linked β-amyloid oligomers'
[patent_app_type] => utility
[patent_app_number] => 11/632784
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 13881
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/955/07955812.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632784
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632784 | Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers | Jul 18, 2005 | Issued |
Array
(
[id] => 5770609
[patent_doc_number] => 20050266490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/176863
[patent_app_country] => US
[patent_app_date] => 2005-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35230
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11176863
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/176863 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 5, 2005 | Abandoned |
Array
(
[id] => 5769007
[patent_doc_number] => 20060019880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Modulation of synaptogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/176450
[patent_app_country] => US
[patent_app_date] => 2005-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17182
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019880.pdf
[firstpage_image] =>[orig_patent_app_number] => 11176450
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/176450 | Modulation of synaptogenesis | Jul 5, 2005 | Abandoned |